This material covers infectious disease and immunity from the core science of the T Level in Health: the pathogens that cause disease, how they spread through a community and a hospital, how the body defends itself, how vaccines work and why antibiotic resistance matters. In the specification used for students starting from September 2026, most of this content belongs to the science paper, one of the two written exams that, with an employer-set project, make up the core assessment; antimicrobial resistance also appears in the health and safety content of the other paper.
You start with the types of pathogen, bacteria, viruses, fungi, protists, prions and parasites, each tied to an example disease and its route of transmission, and with the difference between direct and indirect transmission, including vectors and vehicles. Healthcare-associated infections are studied through MRSA and C. difficile: why they cause problems, who is at risk and why C. difficile spores call for soap and water and enhanced cleaning. You then look at the factors that let disease spread in a community, from crowding and sanitation to vaccination rates and misinformation.
The immunity questions separate antigens from antibodies and non-specific defences from the specific response of T cells and B cells, then use antibody readings after two exposures to show the difference between the primary and secondary response. From there you explain how vaccination creates memory cells and why high uptake protects a community. The last topic is antimicrobial resistance: how resistant strains are selected, why antibiotics are not given for a cold, and what antimicrobial stewardship aims to achieve.
Most quiz questions are short scenarios in invented wards, surgeries and care homes, with one data item. The flashcards hold the key terms. The written work has eight longer tasks, such as comparing MRSA with C. difficile or evaluating ways to reduce resistance, marked against key points. The exam is a conversation with an examiner who asks about one idea at a time and gives brief feedback at the end.
The questions are original practice material and do not predict what a particular exam will ask. The material is for study only and is not medical advice.
Practice material written by Zestly, based on the core content of the Pearson T Level Technical Qualification in Health specification (Version 1.2, July 2026, for students starting from September 2026), content area 8 (Core science concepts), sections 8.9 to 8.14, and content area 2, section 2.9 (antimicrobial resistance). Not endorsed by Pearson or the Department for Education.
Consider the following antibody levels (in arbitrary units) measured in a patient's blood: Day 0 (Exposure 1): 0 units; Day 14: 50 units; Day 28 (Exposure 2): 45 units; Day 35: 500 units. What does this data demonstrate?
The secondary immune response is significantly faster and stronger than the primary response
The jump from 45 to 500 units after the second exposure illustrates the rapid and massive production of antibodies characteristic of the secondary immune response.
T Levels are Department for Education qualifications in England, awarded by licensed awarding organisations; T-LEVELS is a registered trade mark of the Department for Education. BTEC® is a registered trade mark of Pearson Education Ltd. Zestly is not affiliated with or endorsed by the Department for Education or Pearson. These materials are our own.